trending Market Intelligence /marketintelligence/en/news-insights/trending/u21Thn_upb1cyBGyCol9Gw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Esperion plans to offer $150M of common stock

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Esperion plans to offer $150M of common stock

Esperion Therapeutics Inc. plans to offer $150 million of its common stock in an underwritten public offering, subject to market and other conditions.

The company intends to grant the underwriters an option to buy up to an additional $22.5 million of common stock.

Jefferies LLC, Cowen and UBS Investment Bank are acting as joint book-running managers for the proposed offering.